RxDoctor Payments Data

Christina Casillo

Physician Assistant · North Grosvenordale, CTNPI 1336677574

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 678 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,778in general payments, 2019–2025

Across 678 payments — averaging $27.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • GSK$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Boehringer Ingelheim$1K
  • plus $9K from 42 others

What the payments were for

  • Consulting fees$1751%
  • Food & beverage$18,00796%
  • Education$5963%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,778 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$47,468
JardianceEmpagliflozin25$38,446
FarxigaDapagliflozin Propanediol16$22,960
ProliaDenosumab12$20,942
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,525
Duloxetine Hcl39$1,050
Gabapentin29$877
Atorvastatin Calcium79$586
Rosuvastatin Calcium61$557
Pantoprazole Sodium35$537
Oxybutynin Chloride ErOxybutynin Chloride11$510
Albuterol Sulfate HfaAlbuterol Sulfate25$480
Famotidine25$432
Levothyroxine Sodium51$404
Doxycycline Monohydrate26$397

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,456$47,46836 claims
Boehringer IngelheimJardiance$1,150$38,44625 claims
AstraZenecaFarxiga$2,275$22,96016 claims
AmgenProlia$801$20,94212 claims
GSKTrelegy Ellipta$1,813$12,52511 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$38$40451 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in North Grosvenordale

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →